Development of an animal model for autotransfusion therapy: In vitro characterization and analysis of anti-CD3/CD28 expanded cells

Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology

Volumn 19, Issue 3, 1998, Pages 210-220

  Brice, G T ^a   Riley, J L ^b   Villinger, F ^a   Mayne, A ^a   Hillyer, C D ^a   June, C H ^b   Ansari, A A ^a,c  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b HENRY M JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE   (United States)

^c EMORY UNIVERSITY   (United States)

Author keywords

AIDS; CD28; HIV; Nonhuman primate; SIV; T lymphocytes

Indexed keywords

CD28 ANTIBODY; CD28 ANTIGEN; CD3 ANTIBODY; CD3 ANTIGEN; CD4 ANTIGEN; CYTOKINE ANTIBODY; UNCLASSIFIED DRUG;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; HELPER CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MACACA; NONHUMAN; PRIORITY JOURNAL; SIMIAN IMMUNODEFICIENCY VIRUS; T LYMPHOCYTE;

ANIMALIA; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; MACACA; PRIMATES; RNA VIRUSES; SIMIAE; SIMIAN IMMUNODEFICIENCY VIRUS;

EID: 0032213017     PISSN: 10779450     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042560-199811010-00002     Document Type: Article

References (35)

1. Benveniste RE, Morton WR, Clark EA, et al.Inoculation of baboons and macaques with simian immunodeficiency virus/Mne, a primate lentivirus closely related to human immunodeficiency virus type 2. J Virol 1988;62:2091-2101.
2. Letvin NL, Daniel MD, Sehgal PK, et al. Induction of AIDS-like disease in macaque monkeys with T-cell tropic retrovirus STLV-III. Science 1985;230:71-73.
3. McClure HM, Anderson DC, Fultz PN, Ansari AA, Lockwood E, Brodie A. Spectrum of disease in macaque monkeys chronically infected with SIV/SMM. Vet Immunol Immunopathol 1989;21:13-24.
4. + T cell homeostasis and function in advanced HIV disease. Science 1997;277:112-16.
5. Gulick RM, Mellors JW, Havlir D, et al. Treatment with indinavir, zidovudine, and lamivudine in adults with human immunodeficiency virus infection and prior antiretroviral therapy. N Engl J Med 1997;337:734-9.
6. Perelson AS, Essunger P, Yunzhen C, et al. Decay characteristics of HIV-1-infected compartments during combination therapy. Nature 1997;387:188-91.
7. Finzi D, Hermankova M, Pierson T, et al. Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy. Science 1997;278:1295-1300.
8. Wong JK, Hezareh KM, Gmathard HF, et al. Recovery of replication-competent HIV despite prolonged suppression of plasma viremia. Science 1997;278:1291-5.
9. + T-cell repertoire that are not immediately restored by antiviral or immune-based therapies. Nat Med 1997;3: 533-40.
10. + T cell proliferation in HIV-positive patients as a result of CD28 costimulation. Science 1996;272:1939-43.
11. + T cells. Science 1997;276:273-6.
12. Brice GT, Villinger V, Mayne A, Sundstrom JB, Ansari AA. Detection of intracellular signal transduction molecules in PBMC form rhesus macaques and sooty mangabeys. J Med Primatol 1996;25:210-17.
13. Ahmed-Ansari A, Brodie AR, Fultz PN, Anderson DC, Sell KW, McClure HM. Flow microfluorometric analysis of peripheral blood mononuclear cells from nonhuman primates: correlation of phenotype to immune function. Am J Primatol 1989;17:107-31.
14. Riley JL, Carroll RG, Levine BL, et al. Intrinsic resistance to T cell infection with HIV type 1 induced by CD28 costimulation. J Immunol 1997;158:5545-53.
15. Polacino PS, Liang HA, Clark EA. Formation of simian immunodeficiency virus long terminal repeat circles in resting T cells requires both T cell receptor- and IL-2-dependent activation. J Exp Med 1995;182:617-21.
16. + T cells requires a Cyclosporin A-sensitive pathway. J Immunol 1997;158:512-17.
17. Asjo B, Cefai D, Debre P, Duboit Y, Autran B. A novel mode of human immunodeficiency virus type-1 (HIV-1) activation: ligation of CD28 alone induces HIV-1 replication in naturally infected lymphocytes. J Virol 1993;67:4395-8.
18. + T cells from human immunodeficiency virus type-1 infected donors. Proc Natl Acad Sci USA 1993;90:11094-8.
19. Polacino PS, Liang HA, Firpo EJ, Clark EA. T-cell activation influences initial DNA synthesis of simian immunodeficiency virus in resting T lymphocytes from macaques. J Virol 1993;67: 7008-16.
20. Pinchuk LM, Polacino PS, Agy MB, Klaus SJ, Clark EA. The role of CD40 and CD80 accessory cell molecules in dendritic cell-dependent HIV-1 infection. Immunology 1994;1:317-25.
21. Tong-Starksen SE, Luciw PA, Peterlin BM. Signaling through T lymphocyte surface proteins, TCR/CD3 and CD28, activates the HIV-1 long terminal repeat. J Immunol 1989;142:702-7.
22. Ott M, Emiliani S, Lint CV, et al. Immune hyperactivation of HIV-1-infected T cells mediated by tat and the CD28 pathway. Science 1997;275:1481-5.
23. + T-cell derived soluble factor(s), but not β-chemokines RANTES. MIP-1a, and MIP-1b, suppress HIV-1 replication in monocyte/macrophages. Proc Natl Acad Sci USA 1996;93: 15341-5.
24. Marfaing-Koka A, Devergne O, Gorgone G, et al. Regulation of the production of the RANTES chemokines by endothelial cells: synergistic induction by IFN-γ plus TNF-α and inhibition by IL-4 and IL-13. J Immunol 1995;154:1870-8.
25. Schrum S, Probst P, Fleischer B, Zipfel PF. Synthesis of the CC-chemokines MIP-1a, MIP-1b and RANTES is associated with a type 1 immune response. J Immunol 1996;157:3598-3604.
26. Loetscher P, Seitz M, Baggiolini M, Moser B. Interleukin-2 regulates CC chemokine receptor expression and chemotactic responsiveness in T lymphocytes. J Exp Med 1996;184:569-77.
27. Deng H, Unutmaz D, KewalRamani WN, Littman DR. Expression cloning of new receptors used by simian and human immunodeficiency viruses. Nature 1997;388:296-300.
28. Liao F, Alkhatib G, Peden KWC, Sharma G, Berger EA, Farher JM. STRL33, a novel chemokine receptor-like protein, functions as a fusion cofactor for both macrophage-tropic and T cell line-tropic HIV-1. J Exp Med 1997;185:2015-23.
29. +8 T cells. Science 1995;270:1811-15.
30. Amara A, Gall SL, Schwartz O, et al. HIV coreceptor downregulation as antiviral principle: SDF-1a-dependent internalization of the chemokine receptor CXCR4 contributes to inhibition of HIV replication. J Exp Med 1997;186:139-46.
31. Villinger F, Folks TM, Lauro S, et al. Immunological and virological studies of natural SIV infection of disease-resistant nonhuman primates. Immunol Lett 1996;51:59-68.
32. + cells from SIV/SMM infected seropositive clinically asymptomatic sooty mangabeys. J Med Primatol 1990;19:239-49.
33. Lane HC, Depper JM, Greene WC, Whalen G, Waldman TA, Fauci AS. Qualitative analysis of immune function in patients with acquired immunodeficiency syndrome. Evidence for a selective defect in soluble antigen recognition. N Engl J Med 1985;313:79-84.
34. Busch MP, El Amand Z, Sheppard HW, Ascher MS, Lang W. Primary HIV-1 infection. N Engl J Med 1991;325:733-5.
35. Clerici M, Stocks NI, Zajac RA, et al. Detection of three distinct patterns of T helper cells dysfunction in asymptomatic, human immunodeficiency virus-seropositive patients. J Clin Invest 1989; 84:1892-99.